Cellectar Biosciences Inc

CLRB NASDAQ Santé & Biotech États-Unis US15117F8077
3.07 $
0.33 %

Cellectar Biosciences Inc est spécialisée dans le développement de traitements oncolytiques phospholipidiques pour les cancers multiples.

Performance & Momentum

6 Months 15.55 %
1 Year 59.62 %
3 Years 93.05 %
5 Years 99.32 %

Similar stocks to Cellectar Biosciences Inc

Anantys Community

Be the first to share your analysis on Cellectar Biosciences Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases